Stock Analiz

TrueBlue, Inc. TBI

Professional Services · data as of November 13, 2026

$12.41Market cap $378M
Open the interactive analysis →

TrueBlue, Inc. (TBI) is a consumer discretionary company listed in the US with a market value of about $378M. In the twelve months to September 27, 2026 it had revenue of $1.8B and net income of -$45M, a net margin of -2.6%.

Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is shareholder returns (2/5); the weakest is track record (0/5).

Key numbers: 5-year revenue growth of -3% a year, a 5-year average ROIC of -2%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 4% above the current price.

About TrueBlue

TrueBlue is listed in the US and classified in professional services. Revenue went from $2.2B in 2014 to $1.6B in 2025, a decline of about 2.7% a year. It was profitable in 5 of the last 10 years in our data. Its share count fell by 11% over three years (buybacks).

Score: 1.0 / 5

Value1/5
Future growth1/5
Track record0/5
Financial health1/5
Shareholder returns2/5

Checks passed

  • Price below intrinsic value (DCF, moderate assumptions)
  • Profit margin improving
  • Liabilities below 60% of assets
  • Share count down over 3 years (buybacks)
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%

Valuation

P/E (TTM)—
Forward P/E24.8
P/FCF—
P/S0.2
P/B1.4
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-19.1%
Shareholder yield0.0%
Intrinsic value vs. price+4%

Growth and quality

Revenue growth (1 yr)3.1%
Revenue growth (5 yrs, per year)-2.6%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-1.2%
ROIC (5-yr avg.)-2.1%
Profitable years (of last 10)5
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$1.8B$1.6B$1.6B$1.9B$2.3B$2.2B$1.8B$2.4B$2.5B$2.5B$2.8B
Net income-$45M-$48M-$126M-$14M$62M$62M-$142M$63M$66M$55M-$15M
Free cash flow-$72M-$74M-$41M$3M$90M-$15M$125M$65M$109M$78M$232M
EPS (diluted)$-1.55$-1.61$-4.17$-0.45$1.86$1.74$-4.01$1.61$1.63$1.34$-0.37
Net margin-2.6%-3.0%-8.0%-0.7%2.8%2.8%-7.7%2.7%2.6%2.2%-0.5%
ROIC—-9.2%-19.2%-3.1%11.0%10.2%-28.3%8.4%9.6%8.2%-1.9%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 2 analysts is $14.50, 17% above the current price; targets range from $14.00 to $15.00; the consensus rating is “Buy”; expected EPS is $0.07 for the fiscal year ending December 31, 2026.

Frequently asked questions

Is TrueBlue stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 4% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does TrueBlue pay a dividend?

Not currently.

Is TrueBlue a good stock to buy?

We do not give buy or sell advice. TrueBlue scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.